{"id":394,"date":"2023-09-15T18:02:48","date_gmt":"2023-09-15T22:02:48","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=394"},"modified":"2023-09-15T18:02:48","modified_gmt":"2023-09-15T22:02:48","slug":"fdas-new-electronic-portal-for-facility-registration-and-product-listing-of-cosmetic-product-facilities-and-products-under-mocra","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/09\/15\/fdas-new-electronic-portal-for-facility-registration-and-product-listing-of-cosmetic-product-facilities-and-products-under-mocra\/","title":{"rendered":"FDA\u2019s New Electronic Portal for Facility Registration and Product Listing of Cosmetic Product Facilities and Products Under MoCRA"},"content":{"rendered":"<p>Continuing its implementation of the Modernization of Cosmetics Regulation Act\u2019s (MoCRA), and following on the heels of FDA\u2019s\u00a0<a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/draft-guidance-industry-registration-and-listing-cosmetic-product-facilities-and-products\">Draft Guidance<\/a>\u00a0on Facility Registration and Product Listing (previously discussed\u00a0<a href=\"https:\/\/blogs.duanemorris.com\/fashionretailbrandedconsumergoods\/2023\/08\/07\/fda-issues-long-awaited-draft-guidance-for-industry-on-registration-and-listing-of-cosmetic-product-facilities-and-products-under-mocra\/\">here<\/a>), on September 15, 2023, FDA announced its newly developed draft electronic submission portal, Cosmetics Direct, to assist persons submitting cosmetic product facility registrations and product listings under newly added Section 607 of the federal Food, Drug and Cosmetic Act (FD&amp;C Act).<\/p>\n<p>Draft\u00a0<a href=\"https:\/\/www.fda.gov\/media\/171557\/download?attachment\">screenshots<\/a>\u00a0of the electronic system, including example submissions, are available for review and comments, along with an interim\u00a0<a href=\"https:\/\/public-inspection.federalregister.gov\/2023-20139.pdf\">Federal Register Notice<\/a>, announcing the new system.draft guidance,<\/p>\n<p>To read the full post by Duane Morris attorney <a href=\"https:\/\/www.duanemorris.com\/attorneys\/kellyabonner.html\" target=\"_blank\" rel=\"noopener\">Kelly A, Bonner<\/a>, please <a href=\"https:\/\/blogs.duanemorris.com\/fashionretailbrandedconsumergoods\/2023\/09\/15\/introducing-cosmetics-direct-fdas-new-electronic-portal-for-facility-registration-and-product-listing-of-cosmetic-product-facilities-and-products-under-mocra\/\" target=\"_blank\" rel=\"noopener\">visit the <em>Duane Morris Fashion, Retail and Consumer Branded Products Blog<\/em>.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continuing its implementation of the Modernization of Cosmetics Regulation Act\u2019s (MoCRA), and following on the heels of FDA\u2019s\u00a0Draft Guidance\u00a0on Facility Registration and Product Listing (previously discussed\u00a0here), on September 15, 2023, FDA announced its newly developed draft electronic submission portal, Cosmetics Direct, to assist persons submitting cosmetic product facility registrations and product listings under newly added &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/09\/15\/fdas-new-electronic-portal-for-facility-registration-and-product-listing-of-cosmetic-product-facilities-and-products-under-mocra\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA\u2019s New Electronic Portal for Facility Registration and Product Listing of Cosmetic Product Facilities and Products Under MoCRA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[29,641,665,666],"ppma_author":[521],"class_list":["post-394","post","type-post","status-publish","format-standard","hentry","category-general","tag-fda","tag-mocra","tag-portal","tag-submissions"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=394"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/394\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=394"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}